Eos Advisory
Impact investorSt Andrews · Seed–Growth
Also known as Kinburn (209) Llp
Investment thesis
Eos acts as a link between non-specialist investors and science- and technology-intensive companies. Its portfolio spans quality of life and environmental sustainability, covering disease diagnostics, prevention and treatment, food and water security, pollution reduction, clean energy and sustainable infrastructure. The firm seeks commensurate financial returns from early-stage patient capital while backing businesses that generate positive impact. Eos works in long-term partnerships with family offices, individuals, companies and institutional investors, operating across seed and growth stages on a managed or discretionary basis, from multistage multiyear relationships to angel syndicates. It offers S/EIS UK tax relief to eligible investors when available and is committed to diversity and inclusion.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 20 of 22 portfolio companiesHealthtech ×12Biotech ×11Deep Tech ×7Medical Devices ×7Cleantech ×5Hardware ×4AI & Machine Learning ×3New Materials ×3
HQs:United Kingdom×11Italy×1
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×22 founders×23 founders×24+ founders×2
Investments · 22 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 23 dated
TaiSan develops sodium batteries and works with operators, OEMs and research institutions to deploy them into vehicle fleets.
Advanced ManufacturingCleantechEnergyHardwareNew Materials
Co-investorsAdelineEIT InnoEnergyAFI VenturesMercia VenturesTSP VenturesHeartfelt Capital
Bioliberty develops the Lifehub Clinic system, combining soft robotic wearables, gamified therapy, and AI insights to help clinicians deliver physical and occupational therapy to more patients.
Digital HealthMedical DevicesRobotics
CamGene Therapeutics develops RNA-based medicines, including mRNA, siRNA, and antisense oligonucleotides delivered via lipid nanoparticles, to treat the underlying cellular dysfunction that causes hearing loss.
BiotechDeep TechHealthtechCambridge, GB
Arpan Desai(CEO & Co-founder)Prashant Shah(Co-founder)Sunil Shah(Co-founder)
Co-investorsCambridge Angels groupFuture Planet CapitalUK Innovation & Science Seed Fund
Carcinotech produces 3D-bioprinted tumour models using established cancer cell lines and patient-derived tissue, offering assay-ready models and preclinical oncology services for drug testing and translational research.
BiotechDeep TechHealthtechScotland
Albert Nicholl(Director)Ishani Malhotra(Executive Officer, Director)Ian David Waddell(Director)
Chemify builds automated chemical synthesis systems combining chemistry, AI, and robotics to digitize molecular design and manufacturing.
AI & Machine LearningBiotechDeep TechGlasgow, GB
Professor Lee CroninLee Cronin(Founder)in
Co-investorsBlueYard CapitalInsight PartnersHAWKTAILHorizons VenturesLauder PartnersRocketship.vc+3 more
Concinnity Genetics develops control mechanisms to improve the safety of cell and gene therapies, using an AI platform and synthetic biology to help biopharmaceutical partners design and optimise their gene therapies.
AI & Machine LearningBiotechHealthtechEdinburgh, GB
Jessica Birt(Co-founder & CEO)inMatthew Dale(Co-founder & CSO)in
Cumulus Oncology builds a risk-adjusted portfolio of preclinical-stage oncology drug assets, using a platform-agnostic, data- and milestone-driven curation process to advance cancer therapeutics for defined patient populations with high unmet medical need.
BiotechHealthtech
Clare Wareing(CEO)in
Co-investorsAlba EquityApollo Informal InvestmentScottish National Investment Bank
Dxcover develops a multi-omic liquid biopsy platform that combines infrared light spectroscopy and machine learning to detect multiple cancers at an early stage.
AI & Machine LearningBiotechMedical Devices
Co-investorsAlba Equity
ENOUGH produces sustainable food ingredients and works with customers, suppliers, and partners toward its mission.
FoodTechImpact & Social Good
Co-investorsDCVC (Data Collective)
EnsiliTech develops ensilication technology, a silica-based method to stabilise vaccines and biopharmaceuticals so they can be stored and transported without refrigeration.
BiotechCleantechDeep TechHealthtechMedical Devices
Asel Sartbaeva(Co-Founder & CEO)Matt Slade(Co-Founder & Chief of Staff)Stephen Wells(Co-Founder & Advisor)Aswin Doekhie(Co-Founder & CTO)Sabine Ficek(CFO)Simon Bennett(Chief Commercial Officer)
Co-investorsCalculus Capital Ltd.Elbow Beach Capital
GM Flow Measurement Services manufactures gas flow meters, including its adjustable differential pressure cone meter Adjusta-Cone and Hy-Cone products, for use in oil and gas production, hydrogen fuelling, and CO2 carbon capture operations.
CleantechEnergyHardware
ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform.
BiotechDeep TechHealthtechMedical Devices
Owain Millington(CEO)
Co-investorsMedical Incubator Japan K.K.
Laverock develops programmable engineered cell therapies that control gene expression based on cell identity and environment, activating only in the target cell population and tuning expression to precise levels.
BiotechDeep TechHealthtech
Co-investorsFuture Planet CapitalTekfen VenturesUK Innovation & Science Seed Fund
Nami Surgical is a company developing surgical technology and seeks investors and partners across clinical, commercial, and technological domains.
HealthtechMedical DevicesRoboticsGlasgow, GB
Nico Fenu(Co-Founder & Chief Operating Officer)inREBECCA CLEARY(Executive Officer, Director)inNICOLA GIUSEPPE FENU(Executive Officer, Director)Rebecca Cleary(Co-Founder & Chief Technical Officer)inNIKKI PAMELA PALFREY(Director)Nikki Palfrey(Chief Executive Officer)in
Naturbeads develops biodegradable cellulose microspheres to replace microplastics in consumer products such as cosmetics and paints.
Circular EconomyCleantechNew MaterialsItaly, IT
Janet Scott(Co-founder)Davide Mattia(Co-founder)inGiovanna Laudisio(Co-founder)in
Co-investorsInnovate UKCDP Venture CapitalRegeneration.VC
Neupulse develops a wearable device that delivers drug-free, non-invasive neurostimulation to support everyday wellbeing and relaxation, based on neuroscience research.
HardwareHealthtechWellness & Fitness
Developed technology embedding pure silver particles into fibres as an ecologically sound, non-toxic antimicrobial coating for paints and textiles.
SenseBP is a wearable blood pressure monitoring device that eliminates the need for traditional pressure cuffs.
HardwareHealthtech
Co-investorsKelvin Capital
SILVERbac is a patented antimicrobial textile technology that permanently incorporates pure silver particles into fibres, making the treatment non-leaching, non-toxic, and eco-friendly.
Advanced ManufacturingCleantechHealthtechNew MaterialsDubai, GB
Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine.
BiotechDeep TechDigital HealthHealthtechMedical DevicesEdinburgh
Richard Izen Kuo(Executive Officer, Director)Joanna Smart(Director)Lee James Lindley(Director)John Harris Leamon(Director)Trevor John Nicholls(Director)John Robert Fraser Duncan(Director)
Co-investorsIQ Capital
Portfolio news
latest coverage across their companiesCamGene Therapeutics · cambridgeindependent.co.uk · Aug 20, 2026
Naturbeads · intrinsicspring.com · Aug 3, 2026
Chemify · soci.org · Jan 27, 2026
Principals & officers · per Companies House
what is this? ⓘLLP designated member · since 2022
LLP designated member · since 2018
LLP member · since 2020
LLP member · since 2019
LLP member · since 2019
Andrew Paul Mcneill — 25–50% of voting rights, right to share surplus assets 25 to 50 percent limited liability partnership
Frequently asked questions
- How many investments has Eos Advisory made?
- Eos Advisory has 18 tracked investments.
- What stage does Eos Advisory invest at?
- Eos Advisory invests at the Seed, Series A, Growth stages.
- What sectors does Eos Advisory focus on?
- Eos Advisory focuses on AgTech, Biotech, Cleantech, Climate Tech, Deep Tech, Digital Health, Energy, FoodTech, Healthtech, Impact & Social Good, IoT, Medical Devices.
- Where is Eos Advisory located?
- Eos Advisory is headquartered in St Andrews, GB.
- Does Eos Advisory lead rounds?
- Eos Advisory typically participates in rounds rather than leading them.
- Who does Eos Advisory co-invest with?
- Eos Advisory most often shares deals with Alba Equity, Future Planet Capital, UK Innovation & Science Seed Fund, among 18 tracked co-investors.
Media · Podcasts & interviews
featuring the teamSimilar investors
BDC Fund Investments is the fund-of-funds arm of BDC Capital that acts as a limited partner, backing emerging and established fund managers who invest in technology-focused Canadian companies.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Qbic is an inter-university venture capital fund that turns technological breakthroughs from its partner universities, research institutes and hospitals into sustainable businesses.
MDI Ventures is the corporate venture capital arm of Telkom Indonesia, investing in and building synergies between technology startups and Indonesian enterprises. It manages a multi-fund platform (including Centauri Fund, Arise, and sector-specific funds) with a portfolio of 80+ companies.
Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.